CD4 and neoplasm: Additionally, a higher percentage of cells with anti-tumor functions, such as CD4 + IL-2 + T cells and CD56bright NK cells [64], can be detected in the peripheral blood of patients with a favorable prognosis (elevated levels of miR-19a-3p) compared to those with a poor prognosis (low levels of miR-19a-3p).